New York State Common Retirement Fund’s Forte Biosciences FBRX Stock Holding History

New York State Common Retirement Fund’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4	Closed	–	–	3332
2022 Q2	$0	Sell	4 -384	-99%	-$12.2K	﹤0.01%	3496
2022 Q1	$14K	Sell	388 -5	-1%	-$189	﹤0.01%	3304
2021 Q4	$21K	Hold	393	–	–	﹤0.01%	3295
2021 Q3	$29K	Buy	393 +5	+1%	+$2.77K	﹤0.01%	3281
2021 Q2	$326K	Buy	+388	New	+$350K	﹤0.01%	2807
2020 Q2	–	Sell	-46	Closed	-$21K	–	3237
2020 Q1	$21K	Hold	46	–	–	﹤0.01%	3101
2019 Q4	$9K	Hold	46	–	–	﹤0.01%	3193
2019 Q3	$11K	Hold	46	–	–	﹤0.01%	3213
2019 Q2	$115K	Hold	46	–	–	﹤0.01%	3048
2019 Q1	$187K	Hold	46	–	–	﹤0.01%	2747
2018 Q4	$141K	Hold	46	–	–	﹤0.01%	2846
2018 Q3	$268K	Hold	46	–	–	﹤0.01%	2699
2018 Q2	$161K	Hold	46	–	–	﹤0.01%	2975
2018 Q1	$204K	Hold	46	–	–	﹤0.01%	2723
2017 Q4	$176K	Buy	46 +22	+92%	+$87.8K	﹤0.01%	2812
2017 Q3	$112K	Hold	24	–	–	﹤0.01%	2984
2017 Q2	$108K	Buy	+24	New	+$135K	﹤0.01%	3075

Other funds holding FBRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

OWP

Old Well Partners Charlotte, North Carolina $4.55M AUM 27.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund's FBRX Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Forte Biosciences (FBRX) in Q3 2022, closing a stake of 4 shares.

New York State Common Retirement Fund first reported a position in FBRX in Q2 2017 and held it in 17 quarters. The position peaked at $326K in Q2 2021. 33 funds tracked by Wall St. Rank hold FBRX as of Q3 2022.

New York State Common Retirement Fund reported no remaining Forte Biosciences position as of Q3 2022 after selling out during the quarter.
New York State Common Retirement Fund sold 4 Forte Biosciences shares in Q3 2022.
New York State Common Retirement Fund first reported a position in Forte Biosciences in Q2 2017 and held it in 17 quarters.
New York State Common Retirement Fund's Forte Biosciences position peaked at $326K in Q2 2021.
33 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.